Search results
US FDA clears Kyverna’s KYV-101 cell therapy for Phase II SPS trial
Clinical Trials Arena via Yahoo Finance· 6 days ago-cell product candidate designed for use in patients with B cell-driven autoimmune diseases. This...
Heat-related illness is common for those with chronic conditions. Learn from my mistakes.
Durham Herald-Sun via Yahoo News· 15 hours agoLying face down in a strange hotel room, able to hear everything happening in the next room, I...
PolTREG’s regulatory T cell therapy shows promise in type-1 diabetes
BioPharma-Reporter· 2 days agoPolTREG, a Polish biotech company developing Treg therapies, has unveiled results from a clinical...
Panthers fans — and one dog with a front-row seat — rejoice for team’s first Stanley Cup
South Florida Sun Sentinel via Yahoo Sports· 2 days agoSUNRISE — As the Florida Panthers won their first Stanley Cup, 19,939 fans watched with bated breath...
Red flag warning signs of debilitating disease that takes four years to diagnose
Daily Express· 2 days agoYour thyroid gland is a small gland found in the neck, just in front of the windpipe. It is thought...
I Am: Celine Dion Is the Opposite of a Vanity Project
Time via Yahoo News· 2 days agoShe had been stricken with SPS symptoms for nearly two decades before her diagnosis. While initially...
Eye twitching is a sign of several health conditions
Rolling Out· 7 days agoEye twitching — also known as myokymia — is a common phenomenon that most people encounter at some point in their lives.
The 'gene deserts' unravelling the mysteries of disease
BBC News· 1 day agoMutations in these regions of so-called "junk" DNA are increasingly being linked to a range of ...
'Unprecedented' CAR-T results for lupus net Insight prize for researchers
FierceBiotech· 6 days agoTwo scientists whose work sparked industry excitement about the prospect of using chimeric antigen...
CIDP study explores dual-target CAR-T cell therapy for the treatment of relapsed/refractory ...
Medical Xpress· 7 days agoUniversity, together with the team of Professor Guiyun Cui and Wei Zhang from the Affiliated Hospital of Xuzhou Medical University. The team reported for the first time using BCMA-CD19 bispecific ...